Combined Platelet-Rich Plasma and Hyaluronic Acid can Reduce Pain in Patients Undergoing Arthrocentesis for Temporomandibular Joint Osteoarthritis
- PMID: 35679902
- DOI: 10.1016/j.joms.2022.05.002
Combined Platelet-Rich Plasma and Hyaluronic Acid can Reduce Pain in Patients Undergoing Arthrocentesis for Temporomandibular Joint Osteoarthritis
Abstract
Purpose: The benefit of adjuvant medications, such as platelet-rich plasma (PRP) and hyaluronic acid (HA), following arthrocentesis remains controversial. The purpose of this study was to evaluate the efficacy of PRP and HA injection following arthrocentesis in subjects with symptomatic temporomandibular joint osteoarthritis (TMJ-OA).
Methods and materials: The authors implemented a prospective randomized single-blinded pilot clinical study. Healthy adults diagnosed with TMJ-OA who were treated with nonsurgical treatments initially, but failed to respond, participated in this study. Subjects were randomly allocated to HA, PRP, or combined HA+PRP groups following arthrocentesis. The primary outcome variable was the change in pain at 1 and 6 months postoperatively, using the Visual Analogue Scale (VAS). The secondary outcome variables were the changes in maximum mouth opening (MMO), lateral and protrusive mandibular movements, and pathologic TMJ sounds at 1 and 6 months postoperatively. Descriptive and bivariate statistics were computed. The significance level was set at P value < .05, using SPSS 19.
Results: A total of 30 consecutive patients (15 males and 15 females) with a mean age of 29.63 ± 8.34 years were followed for 6 months in this study. The mean reduction in pain at 6 months was 4.1 ± 0.9, 4.1 ± 1.1, and 5.1 ± 1.0 for HA, PRP, and HA/PRP, respectively (P < .05). In all 3 treatment groups, mean VAS parameters had significantly reduced after treatment and these postoperative values were significantly lower in the PRP+HA group (P < .001). The mean increase of MMO after 6 months was 8.0 ± 2.8, 8.0 ± 3.0, and 10.1 ± 3.3 for HA, PRP, and HA/PRP, respectively (P < .05). MMO, lateral, and protrusive mandibular movements significantly improved after treatment in all 3 groups (P < .001). TMJ noises were significantly reduced in all treatment groups (P < .001), but the PRP+HA group exhibited a greater reduction.
Conclusion: Combined HA and PRP injection following arthrocentesis is more effective than HA or PRP alone in the management of TMJ-OA.
Copyright © 2022 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Is arthrocentesis plus platelet-rich plasma superior to arthrocentesis plus hyaluronic acid for the treatment of temporomandibular joint osteoarthritis: a randomized clinical trial.Int J Oral Maxillofac Surg. 2016 Dec;45(12):1538-1544. doi: 10.1016/j.ijom.2016.06.009. Epub 2016 Jun 28. Int J Oral Maxillofac Surg. 2016. PMID: 27364372 Clinical Trial.
-
Synergistic effect of platelet rich plasma with hyaluronic acid injection following arthrocentesis to reduce pain and improve function in TMJ osteoarthritis.J Stomatol Oral Maxillofac Surg. 2023 Feb;124(1S):101340. doi: 10.1016/j.jormas.2022.11.016. Epub 2022 Nov 19. J Stomatol Oral Maxillofac Surg. 2023. PMID: 36414172 Clinical Trial.
-
Intra-articular injection of hyaluronic acid versus platelet-rich plasma following single puncture arthrocentesis for the management of internal derangement of TMJ: A double-blinded randomised controlled trial.J Craniomaxillofac Surg. 2022 Nov;50(11):825-830. doi: 10.1016/j.jcms.2022.10.002. Epub 2022 Oct 27. J Craniomaxillofac Surg. 2022. PMID: 36372680 Clinical Trial.
-
The hierarchy of different treatments for arthrogenous temporomandibular disorders: A network meta-analysis of randomized clinical trials.J Craniomaxillofac Surg. 2020 Jan;48(1):9-23. doi: 10.1016/j.jcms.2019.10.004. Epub 2019 Nov 5. J Craniomaxillofac Surg. 2020. PMID: 31870713 Review.
-
Use of platelet-rich plasma, platelet-rich growth factor with arthrocentesis or arthroscopy to treat temporomandibular joint osteoarthritis: Systematic review with meta-analyses.J Am Dent Assoc. 2018 Nov;149(11):940-952.e2. doi: 10.1016/j.adaj.2018.07.025. J Am Dent Assoc. 2018. PMID: 30724168
Cited by
-
Enhancing Pain Relief in Temporomandibular Joint Arthrocentesis: Platelet-Rich Plasma and Hyaluronic Acid Synergy.Cureus. 2023 Sep 20;15(9):e45646. doi: 10.7759/cureus.45646. eCollection 2023 Sep. Cureus. 2023. PMID: 37868393 Free PMC article. Review.
-
Analysis of the Use of Sample Size and Effect Size Calculations in a Temporomandibular Disorders Randomised Controlled Trial-Short Narrative Review.J Pers Med. 2024 Jun 19;14(6):655. doi: 10.3390/jpm14060655. J Pers Med. 2024. PMID: 38929876 Free PMC article. Review.
-
Efficacy and safety of platelet-rich plasma injections for the treatment of osteoarthritis: a systematic review and meta-analysis of randomized controlled trials.Front Med (Lausanne). 2023 Jun 27;10:1204144. doi: 10.3389/fmed.2023.1204144. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37441691 Free PMC article.
-
Arthrocentesis for temporomandibular joint disorders: a network meta-analysis of randomised controlled trials.BMC Oral Health. 2024 Sep 18;24(1):1108. doi: 10.1186/s12903-024-04858-7. BMC Oral Health. 2024. PMID: 39294620 Free PMC article.
-
Hyaluronic Acid/Platelet-Rich Plasma Mixture Improves Temporomandibular Joint Biomechanics: A Systematic Review.Int J Mol Sci. 2024 Aug 29;25(17):9401. doi: 10.3390/ijms25179401. Int J Mol Sci. 2024. PMID: 39273351 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials